In patients with relapsed or refractory Hodgkin lymphoma treated with nivolumab, PET/CT identified patients with residual disease at CT but who had complete metabolic response and excellent overall... Background CT and fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT performances following immune therapy are not well known in patients with relapsed or refractory Hodgkin lymphoma (RRHL). Purpose...